“…It has never been validated as a stand-alone tool for recurrence screening; however, when these voiding curves were combined with patient-reported symptoms, it has demonstrated 51% sensitivity, 98% specificity, 90% positive predictive value, and 86% negative predictive value. [9] Morey et al were first to use the American Urological Association Symptom Score (AUA-SS) in correlation with uroflowmetry and retrograde urethrogram findings to predict recurrence of USD. [10] In a prospective report, Heyns et al has combined uroflow with AUA-SS and demonstrated 68% specificity for initial diagnosis of USD but its role in the postoperative setting is unknown.…”